Abstract
Anthracyclines are useful chemotherapeutic agents whose utility is limited by the development of irreversible cardiotoxicity. When tested, the pediatric population demonstrates an increased sensitivity to the cardiotoxicity of this class of agents, although the reasons for this increased sensitivity are unclear. The sarcoplasmic reticulum (SR) is a target for anthracycline cardiotoxicity in adults, but the effects of anthracycline on the SR in developing myocardium have not been examined. It may be possible to gain insight into the mechanisms of cardiotoxicity through a comparative approach. We compared the acute effects of doxorubicin, daunorubicin, and caffeine on contractile function in adult and neonatal rabbit myocardium. Frequency-dependent contratility, 90% relaxation times, and postrest potentiated contractions (a uniquely SR-dependent phenomenon) in adult myocardium were inhibited in a concentration-dependent manner. Neonatal myocardium, however, was resistant to the effects of these agents. The degree of contractile dysfunction wa consistent with the difference in SR maturation between adult and developing myocardium Anthracyclines exhibited effects similar to those of caffeine, an agent known to render the Sr nonfunctional by the depletion of the releasable SR calcium pool. These results suggest that anthracyclines induce acute cardiac lesions through effects on the SR in adults, whereas cardiotoxic effects in the developing myocardium may proceed by a different mechanism.
Similar content being viewed by others
References
Young, R.C., Ozols, R.F., and Myers, C.E. (1981). The anthracycline antineoplastic drugs. N. Engl. J. Med. 305:139–153.
Cortes, E.P., Lutman, G., Wanka, J., Wang, J.J., Pickren, J., Wallace, J., et al. (1975). Adriamycin: (NSC-123127) cardiotoxicity; a clinico-pathologic correlation. Cancer Chemother. Rep. 6:215–255.
Alexander, J., Dainiak, N., Berge, H.J., et al. (1979). Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiography. N. Engl. J. Med. 300: 278–283.
Lipshultz, S.E., Colan, S.D., Gelber, R.D., Perez-Atayde, A.R., Sallan, S.E., and Sanders, S.P. (1991). Late effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N. Engl. J. Med. 324:808–815.
Grenier, M.A. and Lipshultz, S.E. (1998). Epidemiology of anthracycline cardiotoxicity in children and adults. Semin. Oncol. 25(4 Suppl. 10):72–85.
Maylie, J.G. (1982). Excitation-contraction coupling in neonatal and adult myocardium of cat. Am. J. Physiol. 242 (Heart Circ. Physiol. 11): H834-H843.
Nakanishi, T. and Jarmakani, J.M. (1984). Developmental changes in myocardial mechanical function and subcellular organelles. Am. J. Physiol. 246 (Heart Circ. Physiol. 15): H651-H625.
Fabiato, A. and Fabiato, F. (1978). Calcium-induced release of calcium from the sarcoplasmic reticulum of skinned cells from adult human, dog, cat, rabbit, rat, and frog hearts and from fetal and newborn rat ventricles. Ann. NY Acad. Sci. 307:491–521.
Wibo, M., Bravo, G., and Godfraind, T. (1990). Postnatal maturation of excitation-contraction coupling in rat ventricle in relation to the subcellular localization and surface density of 1,4-dihydropyridine and ryanodine receptors. Circ. Res. 68:662–673.
Harrer, J.M., Haghighi, K., Kim, H.W., Ferguson, D.G., and Kranias, E.G. (1997). Coordinate regulation of SR Ca-ATPase and phospholamban expression in developing muring heart. Am. J. Physiol. 272 (Heart Circ. Physiol. 41): H57-H66.
Fill, M. and Coronado, R. (1988). Ryanodine receptor channel of sarcoplasmic reticulum. Trends. Neurol. Sci. 11: 453–457.
Page, E., Earley, J., and Power, B. (1974). Normal growth of ultrastructures in rat left ventricular myocardial cells. Circ. Res. 35(Suppl. II):II–12-II–16.
Hirakow, R., Gotoh, T., and Watanabe, T. (1980). Quantitative studies on the ultrastruc tural differentiation and growth of mammalian cardiac muscle cells: I. The atria and ventricles of the rat. Acta. Anat. (Basel) 108:144–152.
Horenstein, M.S., Vander-Heide, R.S., and L'Ecuyer, T.J. (2000). Molecular basis of anthracycline-induced cardiotoxicity and its prevention. Mol. Genet. Metab. 71:436–444.
Solem, L.E., Heller, L.J., and Wallace, K.B. (1996). Dose-dependent increase in sensitivity to calcium-induced mitochondrial dysfunction and cardiomyocyte cell injury by. J. Mol. Cell. Cardiol. 28:1023–1032.
Boucek, R.J., Jr., Olson, R.D., Brenner, D.E., Ogunbunmi, E.M., Inui, M., and Fleischer, S. (1987). The major metabolite of doxorubicin is a potent inhibitor of membrane-associated ion pumps: a correlative study of cardiac muscle with isolated membrane fractions. J. Biol. Chem. 262: 15,851–15,856.
Hagane, K., Akera, T., and Berlin, J.R. (1988). Doxorubicin: mechanism of cardiodepressant actions in guinea pigs. J. Pharmacol. Exp. Ther. 246:655–661.
Boucek, R.J., Jr., Buck, S.H., Scott, F., Oquist, N.L., Fleischer, S., and Olson, R.D. (1993). Anthracy cline-induced tension in permeabilized cardiac fibers: evidence for the activation of the calcium release channel of sarcoplasmic reticulum. J. Mol. Cell. Cardiol. 25:249–259.
Burke, B.E., Gambliel, H., Olson, R.D., Bauaer, F.K., and Cusack, B.J. (2000). Prevention by dexrazoxane of down-regulation of ryanodine receptor gene expression in anthra-cycline cardiomyopathy in the rat. Br. J. Pharmacol. 131: 1–4.
Olson, R.D., Li, X., Palade, P., etal. (2000). Sarcoplasmic reticulum calcium release is stimulated and inhibited by daunorubicin and daunorubicinol. Toxicol. Appl. Pharmacol. 169:168–176.
Arai, M., Tomaru, K., Takizawa, T., et al. (1998). Sarco-plasmic reticulum genes are selectively down-regulated in cardiomyopathy produced by doxorubicin in rabbits. J. Mol. Cell Cardiol. 30:243–254.
Olson, R.D., Mushlin, P.S., Brenner, D.E., et al. (1988). Doxorubicin cardiotoxicity may be due to its metabolite, doxorubicinol. Proc. Natl. Acad. Sci. USA 85:3585–3589.
Pessah, I.N., Durie, E.L., Schiedt, M.J., and Zimany, I. (1990). Anthraquinone-sensitized Ca release channel from rat cardiac sarcoplasmic reticulum: possible receptor-mediated mechanism of doxorubicin cardiomyopathy. Mol. Pharmacol. 37:503–514.
Iarussi, D., Auricchia, U., Agretto, A., et al. (1994). Protective effect of coenzyme Q10 on anthracyclines cardio-toxicity: control study in children with acute lymphoblastic leukemia and non-Hodgkin lymphoma. Mol. Aspects Med. 15(Suppl.):207–212.
Kurabayashi, M., Jeyaseelan, R., and Kedes, L. (1993). Antineoplastic agent doxorubicin inhibits mycgenic differentiation of C2 myoblasts. J. Biol. Chem. 263:5524–5529.
Bers, D.M. (1985). Ca influx and sarcoplasmic reticulum Ca release in cardiac muscle activation during postrest recovery. Am. J. Physiol. 248:H366-H381.
Bouchard, R.A. and Bose, D. (1989) Analysis of the interval-force relationship in rat and canine ventricular myocardium. Am. J. Physiol. 257:H2036-H2047.
Kim, D.H., Landry, A.B. III, Lee, Y.S., and Katz, A.M. (1989). Doxorubicin-induced calcium release from cardiac sarcoplasmic reticulum vesicles. J. Mol. Cell Cardiol. 21:433–436.
DuBell, W.H. and Houser, S.R. (1990). Rest decay of calcium transients and contractility in feline ventricular myocytes. Am. J. Physiol. 259:H395-H402.
Gombosova, I., Boknik, P., Kirechhefer, U., et al. (1998). Postnatal changes in contractile time parameters, calcium regulatory proteins, and phosphatases. Am. J. Physiol. 274 (Heart Circ. Physiol. 43):H2123-H2142
Arai, M., Otsu, K., MacLennan, D.H., and Periasamy, M. (1992). Regulation of sarcoplasmic reticulum gene expression during cardiac and skeletal muscle development. Am. J. Physiol. 262 (Cell Physiol. 31):C614-C620.
Klitzner, T.S. and Freidman, W.F. (1989). A diminished role for the sarcoplasmic reticulum in newborn myocardial contraction: effects of ryanodine. Pediatr. Res. 26:98–101.
Bouchard, R.A. and Bose, D. (1989). Analysis of the interval-force relationship in rat and canine ventricular myocardium. Am. J. Physiol. 257:H2036-H2047.
Sutko, J.L., Bers, D.M., and Reeves, J.P. (1986). Postrest inotropy in rabbit ventricle: Na−Ca exchange determines sarcoplasmic reticulum Ca content. Am. J. Physiol. 250: H654-H661.
Frank, K. and Kranias, E.G. (2000). Phospholamban and cardiac contractility: Review. Ann. Med. 32:572–578.
Yard, N. and Ball, H.A. (1993). Effects of cyclopiazonic acid, an inhibitor of SR Ca ATPase, on the force-frequency relation of guinea-pig atria. Br. J. Pharmacol. 110(Suppl.): 53p.
DuBell, W.H. and Houser, S.R. (1990). Rest decay of calcium transients and contractility in feline ventricular myocytes. Am. J. Physiol. 259:H395-H402.
Langer, G.A. (1992). Calelum and the heart: exchange at the tissue, cell and organelle levels. FASEB J. 6:893–902.
Cusack, B.J., Young, S.P., and Olson, R.D. (1995). Daunorubicin and daunorubicinol pharmacokinetics in plasma and tissues of the rat. Cancer Chemother. Pharmacol. 35: 213–218.
Stewart, D.J., Grewaal, D., Green, R.M., et al. (1993). Concentrations of doxorubicin and its metabolites in human autopsy heart and other tissues. Anticancer Res. 13:1945–1952.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Burke, B.E., Mushlin, P.S., Cusack, B.J. et al. Decreased sensitivity of neonatal rabbit sarcoplasmic reticulum to anthracycline cardiotoxicity. Cardiovasc Toxicol 2, 41–51 (2002). https://doi.org/10.1385/CT:2:1:41
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/CT:2:1:41